Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Desrame J (1999) Oxaliplatin-induced hemolytic anemia. Lancet 354: 1179–1180
Levi JA (1981) Haemolytic anaemia after cisplatin treatment. BMJ 282: 2003–2004
Marani TM (1996) Carboplatin-induced immune hemolytic anemia. Transfusion 36: 1016–1018
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Earle, C., Chen, W., Ryan, D. et al. Oxaliplatin-induced Evan’s syndrome. Br J Cancer 84, 441 (2001). https://doi.org/10.1054/bjoc.2000.1608
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1608
This article is cited by
-
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch
Cancer and Metastasis Reviews (2013)
-
Acute Thrombocytopenia: An Unusual Complication Occurring After Drug-Eluting Microspheres Transcatheter Hepatic Chemoembolization
CardioVascular and Interventional Radiology (2011)
-
Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature
Journal of Hematology & Oncology (2010)
-
Hemolytic uremic syndrome following the infusion of oxaliplatin: case report
BMC Clinical Pharmacology (2006)